The haptenic character of PEG is considered the main culprit in the therapeutic efficacy loss of PEGylated products. [6] High urate levels may have provided an antioxidant defense against aging and cancer. [7]
拟人
While promising, mRNA delivery continues to face challenges including immunogenicity and RNA stability. [8] However, many protein and peptide drugs suffer from short in vivo half-lives which limit their therapeutic applications. [9]
ZhangP，SunF，TsaoC，et al. Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity[J]. Proceedings of the National Academy of Sciences of the United States of America，2015，112(39)：12046-12051.
[7]
ChenX，BurdettT C，DesjardinsC A，et al. Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration[J]. Proceedings of the National Academy of Sciences of the United States of America，2013，110(1)：300-305.
[8]
ZurisJ A，ThompsonD B，ShuY，et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo[J]. Nature Biotechnology，2015，33(1)：73-80.
[9]
DingS，SongM，SimB C，et al. Multivalent antiviral XTEN–peptide conjugates with long in vivo half-life and enhanced solubility[J]. Bioconjugate Chemistry，2014，25(7)：1351-1359.
[10]
朱平盛. 科技论文写作要点[J]. 山东气象，2005，25(103)：8-12.
[11]
陶范. 简洁，科技期刊的语言风格[J]. 编辑学报，2011，23(4)：296-297.
[12]
杨建生. 科技论文写作时的读者意识[J]. 测绘科学，1997(1)：52-53.
[13]
OusteroutD G, KabadiA M, ThakoreP I, et al. Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy[J]. Nature Communications，2015(6)：6244-6252.
